|Day Low/High||30.58 / 35.77|
|52 Wk Low/High||27.65 / 300.00|
"In this world, if you read the papers, darling You know everybody's fighting ah with each other You got no one you can count on babe Not even your own brother So if someone comes along He gonna give you some love and affection I'd say get it while ...
The $5 billion buyback and solid balance sheet could signal this is actually an investible growth stock.
Expert says weed-related products for pets could become a $55 billion-a-year business.
It also beats Nordstrom and Boston Beer Co.
Intelgenx Technologies soars 115% on non-binding letter of intent to work with Tilray.
The only other option is 'to fearfully wait' for the legal-weed industry to expand.
These speculative frenzies all have a number of things in common.
Aggressive traders are beating the bushes looking for the next big mover.
'There's too much hype too soon,' Canopy Growth chief Bruce Linton says.
Let's visit with three charts to see what we can glean about today and tomorrow.
* Tilray is now a sideshow of classic speculative activity - it will likely end badly * Neither go short nor go long * Ignore TLRY and move on, it's a distraction and you may miss other opportunities Henry: (narrating) "And then there was Jimmy Two ...
Covered calls may be the best bet -- or wait for a dip.
Canadian marijuana legalization and U.S. approval of industrial hemp are coming.
Tilray provided good entertainment and there were crazy pockets of momentum.
Cannabis companies should be taking advantage of the mania to raise money.
Tilray isn't the only cannabis stock soaring these days.
Don't try to explain the stock's meteoric rise on a fundamental or technical basis, because it defies both.
"Is there anything at all that can derail this stock market rally?" -- Brian Sullivan, CNBC (today) To me all the ingredients for a market drop are now in place: * Speculative activity is on the rise (materially so in the case of Tilray and others i...
This options trade combines some upside with a chance to buy TLRY at a decent price.
This is absolutely absurd and consistent with an increasingly irrational and speculative market: Today Tilray has a market cap of over $20 billion. This compares to Western Digital at $17.5 billion, Hartford Financial at $18 billion, to Kellogg at $...
At some point Tilray is going to suffer a very ugly drop, but trying to guess when is like trying to time a slot machine.
"The problem with the world is that fools and fanatics are always so certain of themselves and wiser people so full of doubts." -- Bertrand Russell The interest rate for a Tilray borrow is now over 264% -- that's annually! Be forewarned.
The cannabis company has gained DEA approval to import a cannabinoid drug into the U.S.
* Tilray is now a sideshow of classic speculative activity * Neither go short nor go long TLRY * Ignore TLRY and move on Pot stock Tilray, Inc. is trading at $215/share (+$60 in premarket trading). The short squeeze is reminiscent of Robert Wilson'...